Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 137

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 137
---
 risks associated 87

therewith. The Management Projections reflect assumptions as to certain business decisions that are subject to change. Important factors that may affect actual results and cause the Management
Projections not to be achieved include, among others, Enfusion’s ability to successfully expand into Enfusion’s existing markets and into new markets; anticipated trends and growth rates in Enfusion’s business and in the markets in
which Enfusion operates; Enfusion’s ability to retain existing clients and onboard new clients; Enfusion’s ability to sell additional products and services to Enfusion’s clients; Enfusion’s ability to successfully identify,
integrate, and realize the benefits of strategic acquisitions or partnerships; Enfusion’s ability to effectively manage Enfusion’s growth and future expenses; Enfusion’s anticipated investments in Enfusion’s business;
Enfusion’s anticipated capital expenditures; Enfusion’s estimates regarding Enfusion’s capital requirements; Enfusion’s ability to maintain the security and availability of the products and services that comprise Enfusion’s
solution; Enfusion’s ability to maintain, protect, and enhance Enfusion’s intellectual property; Enfusion’s ability to comply with modified or new laws and regulations applying to Enfusion’s business; the attraction and retention
of qualified employees and key personnel; the impact of global financial, economic, public health, and political events on Enfusion’s business and industry; Enfusion’s ability to compete effectively with existing competitors and new market
entrants; and the other risks identified in Enfusion’s SEC filings, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2024, June 30, 2024 and September 30, 2024, and subsequent filings with the SEC, as well as the section titled “Cautionary Note
Regarding Forward-Looking Statements” in this Proxy Statement/Prospectus. Additional factors that may impact us or Enfusion’s business can be found in the various risk factors included in Enfusion’s periodic filings with the SEC. All
of these factors are difficult to predict, and many of them are outside of Enfusion’s control. As a result, there can be no assurance that the Management Projections will be realized, and actual results may be materially better or worse than
those contained in the Management Projections. The Management Projections may differ from publicized analyst estimates and forecasts. You should evaluate the Management Projections, if at all